Biotech R&D cloud platform S-1 filed for 2026 Nasdaq listing. $6.1B valuation, 1,000+ life sciences companies, 120%+ NRR. Founded 2012 in San Francisco.
Benchling is a cloud-based R&D platform for biotech and life sciences companies — essentially a lab operating system. Its software manages experiments, biological samples, workflows, and molecular data for companies developing drugs, food products, agricultural chemicals, and materials. Benchling's platform is used by 8 of the top 20 global pharmaceutical companies and over 1,000 biotechs and life sciences companies. The platform includes an integrated development environment (IDE) for DNA sequence design, protein modeling, and lab automation. Benchling's 120%+ NRR indicates customers are expanding their usage significantly year-over-year — a hallmark of strong product-market fit. Founded by Sachin Das and Stephen Hsu in 2012, Benchling raised from Redpoint, Benchmark, and Thrive Capital.